So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Net Income

Bottom-line profit, the starting point for calculating cash from operations.

So-Young International Inc.NASDAQ: SY

Net Income · Q4 FY2025 · quarter ended Dec 2025

Net income declines year over year

Q4 FY2025 net income of CN¥113.45M (cash outflow) fell 81.3% year over year, behind the -58.1% change in trailing-twelve-month net income. Sequentially, it rose 76.5% from the prior quarter. Over 3 fiscal years it compounded at +55.2% a year.

Context

  • Net income amounted to 16.7% of revenue in FY2025, down 23.4 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 2 analysts of -CN¥206.31M (-16.4%) for the fiscal year ending Dec 2026, a step up from the -58.0% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
-CN¥113.45M+76.5% QoQ
Last fiscal yearDec 2025
-CN¥246.91M-58.0% YoY
LTMDec 2025
-CN¥246.9M-58.1% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-81.3%+187.5%+268.8 pp
1 year-58.0%-16.4%+41.5 pp
3-year CAGR+55.2%——
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

CNY · from the cash flow

Latest · FY2025
(246.91M) CNY
Year-over-year change
+58.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -58.1% is the 9th highest of 11, against a peer median of +23.7%.
  • Net income amounts to 16.3% of revenue for SY, versus a peer median of 84.3%.
SY Competitors
Net Income for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYSo-Young International Inc.LTM Dec 2025CN¥246.9M CNY-58.1%+55.2%16.3%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$222.39M USD-13.8%+21.9%—
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$221.04M USD+23.7%——
ADCTADC Therapeutics S.A.LTM Mar 2026$136.99M USD-8.6%-3.2%173.0%
SNDASonida Senior Living, Inc.LTM Mar 2026$100.48M USD+131.9%+10.0%24.4%
VREXVarex Imaging CorporationLTM Apr 2026$82.7M USD+98.8%—9.6%
OMEROmeros CorporationLTM Mar 2026$81.36M USD+148.9%-73.6%822.4%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$80.17M USD+23.8%-3.4%98.8%
LABStandard BioTools Inc.LTM Mar 2026$78.21M USD+158.9%-26.7%90.7%
SLPSimulations Plus, Inc.LTM Feb 2026$62.79M USD-964.8%—78.0%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026$26.09M USD-85.3%-21.0%37.5%
Peer median (excluding SY) —+23.7%-3.4%84.3%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(37.64M)(66.11M)25.94M(587.18M)(246.91M)
Depreciation & Amortization30.08M47.09M46.09M45.92M57.21M
Deferred Income Tax1.65M(24.8M)(33.52M)(16.17M)(1.79M)
Stock-Based Compensation106.15M43.34M36.32M32.66M8.92M
Change in Working Capital(164.54M)(195M)(122.45M)(167.85M)(26.11M)
Accounts Receivables14.58M13.56M(28.95M)(61.48M)29.72M
Inventory7.87M(27.99M)(2.12M)(36.75M)(115.98M)
Accounts Payables(158.37M)0000
Other Working Capital(28.61M)(180.58M)(91.37M)(69.62M)60.14M
Other Non-Cash Items148.58M82.62M70.11M666.99M103.29M
Operating Cash Flow84.29M(112.87M)22.5M(25.63M)(105.39M)
Capital Expenditures(45.06M)(15.71M)(51.18M)(62.55M)(196.62M)
Acquisitions (Net)(636.87M)(97.49M)000
Purchases of Investments(2.02B)(1.21B)(2.27B)(1.22B)(872.29M)
Sales of Investments3.05B764.79M2.1B1.53B1.03B
Other Investing Activities(8.37M)(18.03M)17.16M10.85M500K
Investing Cash Flow339.82M(572.21M)(202.61M)257.04M(42.81M)
Debt Repayment0029.83M40M(30M)
Common Stock Issued000079K
Common Stock Repurchased(217.71M)(15.12M)(125.62M)(18.24M)(15.25M)
Dividends Paid000(43.57M)(19.03M)
Other Financing Activities969K1.54M(4.22M)298K500K
Financing Cash Flow(216.74M)(13.59M)(100.02M)(21.51M)(63.7M)
Effect of Forex Changes(9.24M)55.86M11.87M3.34M(1.48M)
Net Change in Cash198.12M(642.81M)(268.26M)213.23M(213.38M)
Free Cash Flow39.23M(128.58M)(28.68M)(88.18M)(302.01M)

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.